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February 2011556 AbstractsClinical Efficacy of Endoluminal Interventions for Below Knee Occlu-
sive Disease
Javier E. Anaya-Ayala, MD, Christopher J. Smolock, MD, Ruosu An, BS,
Joseph J. Naoum, MD, Jean Bismuth, MD, Eric K. Peden, MD, Alan B.
Lumsden,MD,MarkG.Davies,MD,Methodist DeBakeyHeart&Vascular
Center, Houston, Tex.
Background: Endovascular therapy for below knee occlusive disease is
increasingly accepted as an alternative to surgical bypass. The objectives of
this study were to evaluate the overall clinical efficacy of below knee
interventions and examine factors influencing their outcomes.
Methods: All patients with critical limb ischemia (Rutherford classes 4,
5, and 6) from 2003 to 2009 who underwent endovascular treatment of
below knee arteries were selected. We identified 194 patients (72% men;
mean age, 68  29 years). End points evaluated were technical success,
cumulative patency, reintervention rates, and limb salvage. Clinical efficacy
was defined as a patient that satisfied all three criteria: vessel segment patent,
patient alive, and free from major amputation. Kaplan-Meier survival analy-
ses were performed to assess time-dependent outcomes. Factor analyses
were performed using a Cox proportional hazard model for time dependent
variables.
Results: A total of 369 below knee interventions were performed in
194 patients, of whom 71% had diabetes and 30% chronic kidney disease
(estimate glomerular filtration rate 60 mL/min/1.72cm3). Indications
for the procedures were tissue loss in 38% and rest pain in the remainder.
Single-vessel intervention was performed in 119 cases, and the rest under-
went multivessel intervention. The vessels intervened on were the below
knee popliteal in 31%, anterior tibial in 32%, the posterior tibial in 30%, and
the peroneal in 28%. According to TransAtlantic InterSociety Consensus
classification, 44% were A and B and 56% were C and D. Overall technical
success rate was 88%. 30-day mortality was 1.4%, and 30-day morbidity was
19%. During a mean follow-up of 2.6 years, 12% died, 28% had occlusion of
a vessel segment, 21% patients underwent amputation (17% minor, 5%,
major), and 26% required two or more reinterventions. The 5-year cumula-
tive patency was 64%. The 5-year limb salvage was 82%. Overall clinical
efficacy was 75% at 1 year but only 40% at 3 years.
Conclusions: Endoluminal intervention for below knee vessel disease
has low mortality but a high morbidity and secondary intervention rate.
Clinical efficacy is good at 1 year but deteriorates rapidly by 3 years.
Analysis of Length of Stay, Cost, and Hospital Disposition in Patients
with Critical Limb Ischemia Treated with Open vs Endovascular
Procedures
Nicholas J. Gargiulo III, MD,1 David J. O’Connor, MD,2 1Albert Einstein
College of Medicine, Bronx; and 2Mount Sinai School of Medicine, New
York, NY.
Objectives: There has been increased emphasis on cost analysis and
length of stay in hospitalized patients to analyze health care costs. Endovas-
cular and open surgical interventions are available for the treatment of
critical limb ischemia (CLI). The aim of our study was to determine if an
open or endovascular procedure had a significant impact on the length of
stay, discharge disposition, cost, or 90-day readmission rate to the hospital.
Methods: We reviewed all patients presenting with CLI from January
1, 2007 to December 31, 2007 at our institution. All patients with Ruther-
ford class 4 or 5 disease underwent initial diagnostic evaluation with con-
ventional arteriography and were treated with open-only, endovascular-
only, or a combination of procedures based on anatomic TransAtlantic
InterSociety Consensus II classification and adequate runoff. Patients were
analyzed for cost of the admission, length of stay, discharge facility disposi-
tion, and readmission rate within 90 days.
Results: Complete data were available for 137 patients: 57 were
endovascular-only, 62 were open-only, and 18 were a combination of both.
The mean length of stay was 9.3  8.66 days for the endovascular group,
10.4  7.89 days for the open group, and 9.8  6.45 days for the hybrid
group. Of patients undergoing an open procedure, 44% were discharged to
a skilled nursing facility or rehabilitation center compared with 35% of
endovascular-only patients and 28% of hybrid patients. The mean cost
hospitalization of an open procedure was $45,832  $23,053 compared
with $49,802  $27,657 in endovascular-only and $27,922  $10,053 in
the hybrid procedure patients. The readmission rate for the endovascular
group was 12% compared with 13% for the open group and 50% for the
hybrid group.
Conclusions: Patients presenting with CLI have shorter lengths of stay
if they undergo an endovascular-only procedure; however, longer admis-
sions are also possible. Hospitalization costs of patients undergoing an
open-only or endovascular-only approach are similar, with similar rates of
readmission. An open bypass procedure, however, places patients at a greater
chance being discharged to a skilled nursing facility. Overall, endovascular
treatment does not offer a cost-saving advantage over open surgical recon-
struction; however, these patients are more likely to recover function for
home placement upon discharge.
t
sunctional Outcomes of Revascularization for Critical Limb Ischemia
regory Landry, MD, Nick Esmonde, Timothy Liem, MD, Erica Mitchell,
D, Gregory Moneta, MD, Oregon Health & Science University, Port-
and, Ore.
Objectives: Outcome measures of revascularization for critical limb
schemia (CLI) have historically been patency, survival, and amputation.
unctional status and quality of life (QOL) assessments have not been well
escribed. This study used functional assessments and QOL questionnaires
o measure patient-centered outcomes after revascularization for CLI.
Methods: Eighteen patients (mean age, 65  11 years) were moni-
ored prospectively before and after lower extremity bypass for CLI. Muscle
trength was assessed preoperatively and postoperatively with tests of knee
nd flexion, ankle dorsiflexion, ankle plantar flexion, elbow and extension,
nd handgrip for ipsilateral and contralateral limbs using the Muscle Func-
ion Evaluation chair (MFEC). Patients completed the Short Physical Per-
ormance Battery (SPPB), which measures walking speed, leg strength, and
alance, a 6-minute walk, and caloric expenditure with an accelerometer.
OL instruments included the Short Form 36 (SF-36), Vascular Quality of
ife (VascuQol).
Results: Ankle-brachial indices (ABI) in the ipsilateral leg increased
.46 0.17 (mean SD) to 0.88 0.21 (P .001). Mean follow-up was
21  57 days. MFEC measurements of ipsilateral leg strength demon-
trated knee flexion increase from 64 63 to 135 133N (P .038). Knee
xtension increased from 120  110 to 186  85 N, which approached
ignificance (P  .062), as did ankle plantar flexion, which increased from
78 126 to 267 252N (P .078). In the contralateral leg, knee flexion
ncreased from 71  96 to 149  162 N (P  .028), and knee extension
ncreased from 162  112 to 239  158 N (P  .036). Nearly all upper
xtremity strength measurements showed an absolute decrease postopera-
ively, but this change was not significant. Absolute improvements were
oted in 6-minute walk distance, daily caloric expenditure, and in individual
omains and overall SPPB scores, although none were significant. The
ascuQol captured the most significant QOL improvement in individual
omains, and overall score (P .015 for each domain). Significant improve-
ent was noted only for Body Pain (P  .011) using the SF-36.
Conclusions: Revascularization for CLI results in improved muscle
trength, leg function, and patient-perceived function using a disease-
pecific questionnaire (VascuQol). Decline in upper extremity strength and
nimproved SF-36 domain scores suggest an overall deconditioning after
evascularization despite leg improvements.
linical Efficacy of Concomitant Tibial Interventions Associated With
FA Interventions in Critical Limb Ischemia
hristopher J. Smolock, MD, Javier E. Anaya Ayala, MD, Jean Bismuth,
D, Joseph J. Naoum, MD, Hosam F. El-Sayed, MD, Heitham Hassoun,
D, Eric K. Peden, MD, Alan B. Lumsden, MD, Mark G. Davies, MD,
hD, The Methodist Hospital, DeBakey Heart and Vascular Center, Hous-
on, Tex.
Background: Combined superficial femoral artery (SFA) and tibial
nterventions are commonplace in the treatment of critical limb ischemia.
oor tibial runoff significantly compromises the durability and clinical
ffectiveness of SFA interventions. The aim of this study was to determine
he clinical and anatomic outcomes of SFA interventions in patients with
qually compromised runoff with and without concomitant tibial angio-
lasty (TA).
Methods: A database of patients undergoing endovascular treat-
ent of the SFA arteries between 1999 and 2009 was retrospectively
ueried. Only patients with poor runoff, defined by a runoff score 10
ere selected. Preoperative angiograms were reviewed to assess distal
opliteal and tibial runoff and were scored according to modified Society
or Vascular Surgery criteria for both vessels such that a higher score
mplies worse runoff (minimum 1; maximum, 19). Kaplan-Meier survival
nalyses were performed to assess time-dependent outcomes. Factor
nalyses were performed using a Cox proportional hazard model for
ime-dependent variables.
Results: A total of 195 limbs with a runoff score 10 (64% male;
verage age, 67 years) underwent endovascular treatment for symptomatic
FA; of whom, 33% underwent TA, while the remainder did not. The
roups were matched for age, gender, and SFA anatomy; however the
resenting symptoms were worse in the TA group. Anatomic outcomes were
quivalent, but freedom from recurrent symptoms and limb salvage were
orse in the TA group (Table).
Conclusions: TA in poor runoff patients has no effect on SFA anatomic
utcomes. Clinical efficacy, as determined by freedom from recurrent symp-
oms, and limb salvage was worse after concomitant TA and was driven by
he presence of critical limb ischemia. Concomitant TA appears not to add
ignificant benefit to SFA in critical limb ischemia.
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Variable No TA TA P
Limbs at risk, No. 128 64 —
Gender (%) 51 71 .16
Age, mean  SD, yrs 69  16 69  14 .1
Rest pain/tissue loss, % 71 94 .0001a
TASC C and D lesions, % 50 61 .17
Mortality, % 0.8 0.0 .1
Morbidity, % 9.4 9.4 .1
Outcomes at 5 years, %
Freedom from recurrent
symptoms
78 70 .04a
Limb salvage 78 69 .04a
Primary patency 59 55 .84
Assisted primary patency 69 79 .33
Secondary patency 71 79 .33
aStatistically significant
Treatment of Type II Endoleaks: Coil Embolization of Lumbar Vessels
Has Poor Long-Term Success
Katherine A. Gallagher, MD, Andrew J. Meltzer, MD, Asad Khan, MD,
Peter Connolly, MD, Fran Aiello, MD, Gautam Shrikhande, MD, Rajeev
Dayal, MD, John Karwowski, MD, Weill Cornell/Columbia University,
New York, NY.
Introduction: The significance of type II endoleak after EVAR is still
controversial. The lack of data for outcomes of intervention in attempts to
seal the leak only obfuscates the issue. The effectiveness and durability of
interventions are important in understanding the meaning of type II en-
doleaks. The purpose of this study was to examine outcomes after interven-
tions for type II endoleaks in our institution.
Methods: We evaluated patients who underwent type II endoleak
treatment at our tertiary care facility from 2001 to 2009. Through aggressive
surveillance imaging, 29 patients showed aneurysm enlargement and type II
endoleak. All patients underwent at least one attempt at percutaneous
intervention. Patients were followed-up postoperatively, both clinically and
radiographically, with a CT angiogram every 3 to 12 months. The outcomes
of patients with expanding type II endoleaks after intervention were ana-
lyzed. Themean postprocedural follow-up was 3.5 years (range, 1-10 years).
Results: A total of 48 interventions on 29 patients (22 men, 7 women;
mean age, 76; range 54-87 years) were performed. Of these, 15 patients
(56%) underwent multiple procedures (2): 9 (31%) underwent two, 5
(17%) had three, and 1 (3.4%) had four separate attempts at treatment.
Three ultimately required elective aortic graft explants. There were no
ruptures in these patients during the time they were followed-up. Seven
patients (24%) had continued endoleak despite multiple treatment attempts.
Of the treatment modalities used, lumbar embolization was the least suc-
cessful, with an 82% failure/recurrence rate. Conversely, IMA coil emboli-
zation had the highest success rate (Table). Three patients had minor
complications (hematoma and wound infection). There were no deaths in
this cohort.
Conclusions: Although initial success is often documented immedi-
ately angiographically, as well as in the short-term, long-term outcomes for
intervention on type II endoleak remain unknown. This study demonstrates
that most patients requiremultiple reinterventions to treat type II endoleaks,
and specifically, lumbar embolization carries a low long-term success rate.
Table. Outcomes based on endoleak intervention
Initial intervention Success Failure Secondary interventi
IMA embolization 8 3 Lumbar embolizatio
IMA embolization
Lumbar embolization 3 14 Lumbar embolizatio
Laparoscopic ligation
Explant
Thrombin gel
IMA embolizationLaparoscopic ligation 0 1 Explantarotid Stenting: The Data of Transcranial Doppler, Cognitive Tests,
nd DWI-MR May Influence Results?
oberto Gattuso, MD, Luigi Irace, MD, Jihad Jabbour, MD, Marco Maria
iuseppe Felli, MD, Federico Faccenna, MD, Antonella Laurito, MD,
lessia Alunno, MD, Anna Castiglione, MD, Bruno Gossetti, MD, Poli-
linico Umberrto, Department of Vascular Surgery, Rome, Italy
Objectives: The purpose of this study was to determine the significance
f microembolic signals (MES) recorded with transcranial Doppler (TCD)
uring carotid artery stenting (CAS). This study was based on analysis of
CD data compared both with changes induced on the brain identified by
iffusion-weighted magnetic resonance imaging (DWI-MR) and with po-
ential neurologic impairment assessed by clinical examination and cognitive
ests.
Methods: From January 2007 to December 2009, 152 patients un-
erwent CAS: 112 were asymptomatic (73.8%) and 40 were symptomatic
26.2%). As assessed by duplex scanning, all carotid stenosis were hemody-
amically significant and plaques had echomorphologic features of stability.
CAS was successfully done in 150 patients (98.7%). Cerebral protection
lter devices were used in all patients. Before the procedure, 60 minutes of
CDmonitoring was performed to detect MES in order to exclude embolic
laques. TCD monitoring was carried out throughout the procedures and
or 60 minutes after. In all patients, neurologic examination associated to
ognitive tests and DWI-MR were carried out preoperatively and postoper-
tively. Statistical analysis was performed by means the binomial test (P 
50) and the Fischer exact test.
Results: There were no deaths. Five minor stokes occurred during the
rocedure, and all were related to40MES; one major stroke was observed
ostoperatively. Fewer than 40 MES were recorded in 97 cases; in this
roup, postoperative DW-MRI showed new ischemic lesions in 18 (18.5%,
 .0009). In 48 patients was recorded MES 40 either during catheter-
zation of carotid arteries and during cerebral protection filter placement (27
atients, group A) or during stent placement and ballooning (21 cases,
roup B). Postoperative DW-MRI showed new ischemic lesions in 21 of 27
atients of group A and in all patients of group B, with a statistically
ignificant correlation. Comparison ofMRI data with those of cognitive tests
howed a statistical significant correlation between DWI lesions and post-
perative cognitive impairment (P .00001). Symptomatic patients suffer-
ng from minor or major strokes had DW-MRI lesions 20 mm2.
Conclusions: Our data suggest that even in selective patients under-
oing CAS, when intraprocedural TCD records 40 MES during stent
eployment, there is a high odds ratio new ischemic lesions will develop as
etected by DW-MRI, combined with postprocedural cognitive impair-
ent.
National Survey of The Use of Anti-Platelet Medications and Prota-
ine During Carotid Endarterectomy and Carotid Artery Stenting:
hat Is the Standard?
lizabeth M. Quiroz, BA, Ross Milner, MD, Loyola University Medical
enter, Maywood, Ill.
Objectives: The use of anticoagulation during carotid endarterectomy
CEA) and carotid artery stenting (CAS) has been standard practice for
any years. However, reversal with protamine sulfate has not been a
ormally standardized process. In our study, we assessed the anticoagulation
herapies most commonly used before, during, and after these procedures.
n addition, we evaluated the percentage of vascular surgeons that perform
arotid artery interventions.
Methods: Members of the Society of Vascular Surgery were sent an
-mail survey by Survey Monkey with 16 multiple-choice questions about
EA and CAS anticoagulation management. The questions addressed the
hoices of antiplatelet therapy before the procedure, assessment of platelet
nhibition before the procedure, anticoagulation therapy during the proce-
Success Failure Subsequent interventions Success Failure
1
1
2 3 Lumbar embolization 2 4
1 2 Explant 1
1
1
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